Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice
An observational real-world cohort study evaluated the safety and efficacy of Micardis (telmisartan) taken once daily at 40 mg/day and 80 mg…
-
CLINICAL_TRIALS trial_result · 2010-03-23Clinical Trial Update: Candesartan Effect in Second Stage Arterial Hypertension [Phase 4]
A Phase 4 trial evaluating candesartan for Stage II hypertension has completed. The results were posted on 2010-03-23.
-
FDA approval · 2010-03-17FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Benazepril hydrochloride and hydrochlorothiazide from Sandoz Inc.
-
FDA approval · 2010-03-16FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
FDA approves a supplemental application for Cardura XL (doxazosin mesylate) by Viatris Specialty LLC to modify or expand the labeling.
-
FDA approval · 2010-03-15FDA Approved: MATZIM LA — Original Application (Actavis Pharma, Inc.)
FDA approved MATZIM LA, a diltiazem hydrochloride extended-release tablet, under Actavis Pharma's original ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-03-12FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2010-03-12Clinical Trial Update: Hypertension in Primary Health Care: Lifestyle Change and Blood Pressure Goals [NA]
A completed clinical trial led by Karolinska Institutet evaluating lifestyle modification and blood pressure goals for hypertension in prima…
-
FDA approval · 2010-03-11FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (TruPharma, LLC)
The FDA approved a supplemental application for clonidine hydrochloride (generic) from TruPharma, LLC.
-
FDA approval · 2010-03-10FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for metoprolol tartrate.
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen
Update on a completed clinical trial evaluating a telmisartan-based antihypertensive regimen; results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination [Phase 3]
An open-label, long-term Phase 3 study of a telmisartan/amlodipine fixed-dose combination for hypertension was completed. Results have been …
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 Years [Phase 4]
Phase 4 trial evaluating the efficacy and safety of lacidipine and amlodipine on blood pressure in elderly Korean patients with isolated sys…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: A Self-care Intervention for Latino Adults With Diabetes [Phase 2]
Phase 2 trial evaluating a self-care intervention for Latino adults with diabetes; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Improving Outcomes in Patients With Kidney Disease Due to Diabetes [Phase 2]
A Phase 2 clinical trial investigating an intervention to improve outcomes in patients with diabetic kidney disease has completed.
-
CLINICAL_TRIALS research · 2010-03-02Clinical Trial Update: Improving Diabetes in Primary Care (IMPACT)
The IMPACT trial (Improving Diabetes in Primary Care), sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases, ev…
-
FDA approval · 2010-02-26FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original application for hydralazine hydrochloride, a generic antihypertensive. The approval covers a product manufactured …
-
FDA approval · 2010-02-19FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
FDA approved a supplemental application for the lisinopril and hydrochlorothiazide combination from GSMS, Incorporated. The document provide…
-
FDA approval · 2010-02-19FDA Approved: BYSTOLIC — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for BYSTOLIC (nebivolol hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2010-02-17FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories to market a generic fixed-dose combination of amlodipine besylate and atorv…
-
FDA approval · 2010-02-17FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for NORVASC (amlodipine besylate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS research · 2010-02-15Clinical Trial Update: Improving Medication Adherence in Comorbid Conditions [NA]
This clinical trial update notes completion of an NIH-sponsored study aimed at improving medication adherence in individuals with Type 2 dia…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA) [Phase 2]
A Phase 2 trial of alagebrium (SPECTRA) for hypertension has been terminated; this delivers a status update on the trial.
-
FDA approval · 2010-02-05FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin's amlodipine besylate and benazepril hydrochloride as an original-application generic product for hypertension.
-
FDA approval · 2010-02-04FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2010-02-04FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Hydralazine Hydrochloride submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceutic…